Hemostatic Disorders
Welcome,         Profile    Billing    Logout  
 195 Companies   327 Products   327 Products   167 Mechanisms of Action   13 Trials   3266 News 


«12...1516171819202122232425...6768»
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  MM-FISH/DNA: The Molecular Characterization of Multiple Myeloma at Relapse (clinicaltrials.gov) -  Jan 8, 2016   
    P=N/A,  N=134, Completed, 
    Not yet recruiting --> Recruiting Active, not recruiting --> Completed | N=240 --> 134 | Trial primary completion date: Feb 2013 --> Dec 2014
  • ||||||||||  Trial completion, Trial primary completion date:  Cancer Stem Cells in Multiple Myeloma (clinicaltrials.gov) -  Jan 6, 2016   
    P=N/A,  N=96, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Jun 2013 --> Jan 2016
  • ||||||||||  bortezomib / Generic mfg., bendamustine / Generic mfg.
    Trial completion:  Bortezomib and Bendamustine to Treat Relapsed/Refractory Myeloma (clinicaltrials.gov) -  Jan 4, 2016   
    P2,  N=24, Completed, 
    Active, not recruiting --> Terminated; PI left the institution Active, not recruiting --> Completed
  • ||||||||||  Proleukin (aldesleukin) / Merck (MSD), Novartis, Iovance Biotherap
    Enrollment change:  Interleukin-2 Treatment for Wiskott-Aldrich Syndrome (clinicaltrials.gov) -  Dec 31, 2015   
    P1,  N=15, Recruiting, 
    Active, not recruiting --> Terminated | Trial primary completion date: Mar 2016 --> Nov 2015; PI left the institution N=11 --> 15
  • ||||||||||  Trial primary completion date:  Honey in Chronic Immune Thrombocytopenia (clinicaltrials.gov) -  Dec 29, 2015   
    P2,  N=30, Suspended, 
    N=11 --> 15 Trial primary completion date: Nov 2014 --> Jan 2016
  • ||||||||||  Trial primary completion date, Surgery:  INWOUND: Wound Healing Abnormalities in Major Abdominal Surgery (clinicaltrials.gov) -  Dec 29, 2015   
    P=N/A,  N=260, Recruiting, 
    Trial primary completion date: Nov 2014 --> Jan 2016 Trial primary completion date: Jun 2016 --> Oct 2016
  • ||||||||||  rocilinostat (ACY-1215) / Regenacy
    Enrollment closed, Trial primary completion date, Combination therapy, Monotherapy:  Study of ACY-1215 Alone and in Combination With Bortezomib and Dexamethasone in Multiple Myeloma (clinicaltrials.gov) -  Dec 29, 2015   
    P1/2,  N=120, Active, not recruiting, 
    Trial primary completion date: Jul 2016 --> Dec 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2015 --> Jun 2016
  • ||||||||||  Enrollment closed, Trial primary completion date:  MBD: Standardisation of Investigations of Mild Bleeding Disorders (clinicaltrials.gov) -  Dec 23, 2015   
    P=N/A,  N=300, Active, not recruiting, 
    Trial primary completion date: Aug 2015 --> Aug 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2015 --> Apr 2016
  • ||||||||||  BeneFix (nonacog alfa) / Pfizer
    Trial primary completion date, Adverse events:  Registry For Patients Treated With BeneFix In Usual Care Setting In Germany (clinicaltrials.gov) -  Dec 23, 2015   
    P=N/A,  N=100, Recruiting, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2015 --> Apr 2016 Trial primary completion date: Apr 2016 --> Oct 2017
  • ||||||||||  Xyntha (moroctocog alfa) / Pfizer
    Trial primary completion date, Adverse events:  Study Evaluating Pharmacovigilance Of Refacto AF (clinicaltrials.gov) -  Dec 19, 2015   
    P=N/A,  N=140, Recruiting, 
    Active, not recruiting --> Completed | N=47 --> 14 | Trial primary completion date: Sep 2015 --> Dec 2015 Trial primary completion date: Apr 2016 --> Oct 2017
  • ||||||||||  bortezomib / Generic mfg.
    Trial primary completion date:  Autophagy Induction After Bortezomib for Myeloma (clinicaltrials.gov) -  Dec 16, 2015   
    P0,  N=15, Recruiting, 
    Not yet recruiting --> Recruiting Trial primary completion date: Apr 2015 --> Apr 2016
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  OSA in EDS: Obstructive Sleep Apnoea in Ehlers-Danlos Syndrome (clinicaltrials.gov) -  Dec 12, 2015   
    P=N/A,  N=200, Completed, 
    N=40 --> 0 Enrolling by invitation --> Completed | N=100 --> 200 | Trial primary completion date: Jul 2017 --> Dec 2015
  • ||||||||||  carfilzomib / Generic mfg.
    P1/2 data:  Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma (clinicaltrials.gov) -  Dec 10, 2015   
    P1/2,  N=184, Active, not recruiting, 
    N=48 --> 7 | Recruiting --> Terminated | Trial primary completion date: Sep 2018 --> Oct 2015; Safety lead-in data did not support continuation of study. Trial primary completion date: Jul 2014 --> Oct 2014
  • ||||||||||  plerixafor / Generic mfg.
    Biomarker, Enrollment change, Trial termination, Trial primary completion date, Tumor microenvironment:  Pilot Study of Lymphoid Tumor Microenvironmental Dysruption Prior to Autologous Stem Cell Transplantation (clinicaltrials.gov) -  Dec 4, 2015   
    P1,  N=7, Terminated, 
    Trial primary completion date: Dec 2015 --> Mar 2016 N=16 --> 7 | Recruiting --> Terminated | Trial primary completion date: Aug 2015 --> Mar 2017; Unavailability of study article
  • ||||||||||  Kymriah (tisagenlecleucel-T) / Novartis
    Enrollment closed:  CART-19 for Multiple Myeloma (clinicaltrials.gov) -  Dec 4, 2015   
    P1,  N=13, Active, not recruiting, 
    Recruiting --> Completed | N=20 --> 8 Completed --> Active, not recruiting
  • ||||||||||  Trial primary completion date:  Impact of Vasculitis on Employment and Income (clinicaltrials.gov) -  Dec 4, 2015   
    P=N/A,  N=400, Recruiting, 
    Completed --> Active, not recruiting Trial primary completion date: Sep 2015 --> Jan 2016
  • ||||||||||  lenalidomide / Generic mfg.
    Trial primary completion date:  IFM2005-02: Maintenance Therapy Using Lenalidomide in Myeloma (clinicaltrials.gov) -  Nov 30, 2015   
    P3,  N=614, Active, not recruiting, 
    Trial primary completion date: Sep 2015 --> Jan 2016 Trial primary completion date: Sep 2015 --> Sep 2016